US Economic Growth Revised Lower FirstQuarter GDP Downgraded to 16 Spotify Shares Surge on AI Music Partnership with UMG and Upbeat Guidance Stellantis Turnaround Plan Prediction Market Regulation Oura IPO Filing Morning Market Brief JK Tyre Unveils Rs 4900 Crore Capex Plan to Boost Capacity by 24 by FY30 SpaceX IPO Charts Reveal Spending Patterns Mimicking AI Giants Ahead of Potential Public Listing Healthcare Technology Revolution Sensors 3D Printing and Personalized Medicine Reshape Industry NAKA Q4 2025 Earnings Significant EPS Miss Sends Shares Lower FCPT Q1 2026 Earnings EPS Misses Estimates Shares Edge Higher SunCoke Energy SXC Q1 2026 Earnings EPS Misses Estimates by 6956 Despite Sharp Stock Rally ROKU Q1 2026 Earnings Strong EPS Beat Drives Positive Investor Sentiment SWMR Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Surges 139 Calavo Growers Q1 2026 Earnings EPS Beats Estimates by 23 Amid Operational Improvements Telomir Pharmaceuticals TELO Consolidates Near 129 as Support and Resistance Levels Tighten RANGR Rights Hold Steady at 029 Testing Key Resistance Barrier Taiwan Semiconductor TSM Edges Higher Key Levels to Watch Amid Sector Strength TransMedics Group TMDX Moves Higher Key Support and Resistance Levels in Focus Douglas Elliman DOUG Trades Lower as Real Estate Headwinds Persist Ferraris 550000 Electric Car Launch Luce Design Sparks Criticism Shares Tumble Flanigans Enterprises Inc BDL Q3 2025 Earnings Positive EPS Performance Despite Lack of Consensus Estimates Oshkosh Corporation OSK Edges Higher as Investors Assess Defensive Positioning and Technical Levels SUPV Q1 2026 Earnings Massive EPS Beat as Company Swings to Profitability General Mills Q1 2026 Earnings EPS Misses Estimates by Nearly 13 as Stock Edges Higher VEON Q1 2026 Earnings EPS Beats Estimates Amid Operational Progress StandardAero Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction Sylvamo Corporation SLVM Q1 2026 Earnings A Wide Earnings Miss Amidst Market Headwinds Curis Inc Q1 2026 Earnings Deep EPS Miss as PreRevenue Biotech Continues Development ZBIO Q1 2026 Earnings NarrowerthanExpected Loss but Stock Declines